Notably, HMGA1 and NUDT16 were highly expressed in radioresistant cell lines, and targeting NUDT16-HMGA1 pathway significantly enhanced the sensitivity of tumor cells to chemotherapy and IR treatment (Fig. 7). The gene discussed is HMGA1; the disease is neoplasm.